Kingswood Wealth Advisors LLC Has $912,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Kingswood Wealth Advisors LLC raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 315.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 81,730 shares of the pharmacy operator's stock after purchasing an additional 62,053 shares during the quarter. Kingswood Wealth Advisors LLC's holdings in Walgreens Boots Alliance were worth $912,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Riverview Trust Co increased its stake in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after buying an additional 1,590 shares during the last quarter. Colonial Trust Co SC grew its holdings in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,297 shares in the last quarter. Sentry Investment Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the first quarter valued at about $27,000. Curat Global LLC bought a new stake in Walgreens Boots Alliance during the first quarter worth about $27,000. Finally, Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth about $28,000. 58.59% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of the company's stock in a transaction on Sunday, April 27th. The stock was acquired at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman now directly owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 17.50% of the company's stock.

Analyst Upgrades and Downgrades

WBA has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price target for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Finally, Wall Street Zen assumed coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a "hold" rating on the stock. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $11.39 on Friday. The firm has a market cap of $9.86 billion, a P/E ratio of -1.70, a price-to-earnings-growth ratio of 1.37 and a beta of 0.78. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.32 and a current ratio of 0.61. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $16.25. The firm's 50-day simple moving average is $11.15 and its 200 day simple moving average is $10.73.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. The company had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 16.39% and a negative net margin of 3.80%. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.20 earnings per share. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.